Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein.

References

1. Appel K., Wagner P., Boldyreff B., Issinger O., Montenarh M. 1995; Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta sub-unit of protein kinase CK2. Oncogene 11:1971–1978
   [Google Scholar]
2. Balsano C., Billet O., Bennoun M., Cavard C., Zider A., Grimber G., Natoli G., Briand P., Levrero M. 1994; Hepatitis B virus X gene product acts as a transactivator in vivo . Journal of Hepatology 21:103–109
   [Google Scholar]
3. Beasley R. P., Hwang L. Y. 1984; Hepatocellular carcinoma and hepatitis B virus. Seminars in Liver Disease 4:113–121
   [Google Scholar]
4. Chirillo P., Pagano S., Natoli G., Puri P. L., Burgio V. L., Balsano C., Levrero M. 1997; The hepatitis B virus X gene induces p53- mediated programmed cell death. Proceedings of the National Academy of Sciences, USA 94:8162–8167
   [Google Scholar]
5. Doria M., Klein N., Lucito R., Schneider R. J. 1995; The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO Journal 14:4747–4757
   [Google Scholar]
6. Feitelson M. A., Zhu M., Duan L. X., London W. T. 1993; Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109–1117
   [Google Scholar]
7. Gorman C. 1985; High efficiency gene transfer into mammalian cells. In DNA Cloning - A Practical Approach pp. 143–190 Glover D. Edited by Washington & Oxford: IRL Press;
   [Google Scholar]
8. Henkler F., Koshy R. 1996; Multiple functions of the hepatitis B virus X protein. Viral Hepatitis Reviews 2:143–159
   [Google Scholar]
9. Hildt E., Hofschneider P. H., Urban S. 1996; The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Seminars in Virology 7:333–347
   [Google Scholar]
10. Hinds P. W., Weinberg R. A. 1994; Tumor suppressor genes. Current Opinion in Genetics and Development 4:135–141
    [Google Scholar]
11. Hoffmann B., Piasecki A., Paul D. 1989; Proliferation of fetal rat hepatocytes in response to growth factors and hormones in primary culture. Journal of Cell Physiology 139:654–662
    [Google Scholar]
12. Höhne M., Piasecki A., Ummelmann E., Paul D. 1987; Transformation of differentiated neonatal rat hepatocytes in primary culture by polyoma virus early region sequences. Oncogene 1:337–345
    [Google Scholar]
13. Höhne M., Schaefer S., Seifer M., Feitelson M. A., Paul D., Gerlich W. H. 1990; Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO Journal 9:1137–1145
    [Google Scholar]
14. Höhne M. W., Zieroth S., Veser U., Kahl G. F., Schwarz L. R. 1993; Carcinogen-induced diploid hepatocytes: sensitive target cells for transformation by mutated c-Ha-ras oncogene. Molecular Carcinogenesis 7:180–189
    [Google Scholar]
15. Kim C. M., Koike K., Saito I., Miyamura T., Jay G. 1991; HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317–320
    [Google Scholar]
16. Klein R., Schröder C. H., Zentgraf H. 1991; Expression of the X protein of hepatitis B virus in insect cells using recombinant baculoviruses. Virus Genes 5:157–174
    [Google Scholar]
17. Kunkel T. A. 1985; Rapid and efficient site-specific mutagenesis without phenotypic selection. Proceedings of the National Academy of Sciences, USA 82:488–492
    [Google Scholar]
18. Lane D. P., Stephen C. W., Midgley C. A., Sparks A., Hupp T. R., Daniels D. A., Greaves R., Reid A., Vojtesek B., Picksley S. M. 1996; Epitope analysis of the murine p53 tumour suppressor protein. Oncogene 12:2461–2466
    [Google Scholar]
19. Lee T. H., Finegold M. J., Shen R. F., DeMayo J. L., Woo S. L., Butel J. S. 1990; Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. Journal of Virology 64:5939–5947
    [Google Scholar]
20. Luber B., Arnold N., Stürzl M., Höhne M., Schirmacher P., Lauer U., Wienberg J., Hofschneider P. H., Kekulé A. S. 1996; Hepatoma-derived integrated HBV-DNA causes multi-stage transformation in vitro . Oncogene 12:1597–1608
    [Google Scholar]
21. Mosner J., Mummenbrauer T., Bauer C., Sczakiel G., Grosse F., Deppert W. 1995; Negative feedback regulation of wild-type p53 biosynthesis. EMBO Journal 14:4442–4449
    [Google Scholar]
22. Müller E., Boldyreff B., Scheidtmann K. H. 1993; Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells. Oncogene 8:2193–2205
    [Google Scholar]
23. Myers R. M., Larin Z., Maniatis T. 1985; Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes. Science 230:1242–1246
    [Google Scholar]
24. Oguey D., Dumenco L. L., Pierce R. H., Fausto N. 1996; Analysis of the tumorigenicity of the X gene of HBV in a non-transformed hepatocyte cell line and the effects of cotransfection with murine p53 mutant equivalent to human codon 249. Hepatology 24:1024–1033
    [Google Scholar]
25. Paul D., Höhne M., Pinkert C., Piasecki A., Ummelmann E., Brinster R. L. 1988; Immortalized differentiated hepatocyte lines derived from transgenic mice harboring SV40 T-antigen genes. Experimental Cell Research 175:354–362
    [Google Scholar]
26. Perfumo S., Amicone L., Colloca S., Giorgio M., Pozzi L., Tripodi M. 1992; Recognition efficiency of the hepatitis B virus poly-adenylation signals is tissue specific in transgenic mice. Journal of Virology 66:6819–6823
    [Google Scholar]
27. Robinson W. S. 1994; Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annual Review of Medicine 45:297–323
    [Google Scholar]
28. Rogler C. E., Chisari F. V. 1992; Cellular and molecular mechanisms of hepatocarcinogenesis. Seminars in Liver Disease 12:265–278
    [Google Scholar]
29. Schaefer S., Gerlich W. H. 1995; In vitro transformation by hepatitis B virus DNA. Intervirology 38:143–154
    [Google Scholar]
30. Scheidtmann K. H. 1989; SV40 large T antigen induces a protein kinase responsible for phosphorylation of the cellular protein p53. Current Topics in Microbiology and Immunology 144:85–88
    [Google Scholar]
31. Schek N., Bartenschlager R., Kuhn C., Schaller H. 1991; Phosphorylation of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 6:1735–1744
    [Google Scholar]
32. Schmieg F. I., Simmons D. T. 1984; Intracellular location and kinetics of complex formation between simian virus 40 T antigen and cellular protein p53. Journal of Virology 52:350–355
    [Google Scholar]
33. Seifer M., Gerlich W. H. 1992; Increased growth of permanent mouse fibroblasts in soft agar after transfection with hepatitis B virus DNA. Archives of Virology 126:119–128
    [Google Scholar]
34. Seifer M., Heermann K. H., Gerlich W. H. 1990a; Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts. Virology 179:287–299
    [Google Scholar]
35. Seifer M., Heermann K. H., Gerlich W. H. 1990b; Replication of hepatitis B virus in transfected nonhepatic cells. Virology 179:300–311
    [Google Scholar]
36. Seifer M., Höhne M., Schaefer S., Gerlich W. H. 1991; In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. Journal of Hepatology 13:S61–S65
    [Google Scholar]
37. Shin S. I., Freedman V. H., Risser R., Pollack R. 1975; Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro . Proceedings of the National Academy of Sciences, USA 72:4435–4439
    [Google Scholar]
38. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K. 1989; The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Japanese Journal of Cancer Research 80:617–621
    [Google Scholar]
39. Su F., Schneider R. J. 1997; Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proceedings of the National Academy of Sciences, USA 94:8744–8749
    [Google Scholar]
40. Takada S., Kaneniwa N., Tsuchida N., Koike K. 1997; Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 15:1895–1901
    [Google Scholar]
41. Treinin M., Laub O. 1987; Identification of a promoter element located upstream from the hepatitis B virus X gene. Molecular and Cellular Biology 7:545–548
    [Google Scholar]
42. Truant R., Antunovic J., Greenblatt J., Prives C., Cromlish J. A. 1995; Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. Journal of Virology 69:1851–1859
    [Google Scholar]
43. Ueda H., Ullrich S. J., Gangemi J. D., Kappel C. A., Ngo L., Feitelson M. A., Jay G. 1995; Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genetics 9:41–47
    [Google Scholar]
44. Wang X. W., Forrester K., Yeh H., Feitelson M. A., Gu J. R., Harris C. C. 1994; Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proceedings of the National Academy of Sciences, USA 91:2230–2234
    [Google Scholar]
45. Wang X. W., Gibson M. K., Vermeulen W., Yeh H., Forrester K., Sturzbecher H. W., Hoeijmakers J. H., Harris C. C. 1995; Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Research 55:6012–6016
    [Google Scholar]
46. Zahm P., Hofschneider P. H., Koshy R. 1988; The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3:169–177
    [Google Scholar]